hmm The Record · ex-9 / 38

02 · The exits → Australia

Markets · Australia

Why Australia.

The regulatory architecture, the company universe, and the exit pathway across the five Necessities in Australia.

The window01 / 02
EX-1 The window

Australia. In-flight regulations by year.

Each bar counts effective dates in Australia between 2024 and 2030.

2024 1 2025 1 2026 1 2027 8 2028 0 2029 0 2030 0 Peak crystallisation 2027. 8 regulations
Sourcehmm Ventures regulatory dataset.
The market02 / 02

Australia carries the deepest Necessity-aligned regulatory architecture of the four markets, with mature statutory regimes in every sector hmm backs. The country’s industrial capability is greatest in exactly the sectors where the regulation runs deepest: critical materials, power systems, biomedical systems, food security, and autonomous systems. Each has a discrete approval pathway, and each pathway is the barrier that screens for an investable company.

Australia is also the Trans-Tasman gateway into New Zealand, through FSANZ food-standards alignment and Medsafe-TGA mutual recognition. The construction window is in flight: the National Construction Code 2025 publishes in May 2026, with phased state adoption through 2026 and 2027.

Australia, current state

  • Critical Minerals Strategy: A$4 billion strategy 2023-2030; Critical Minerals Office at the Department of Industry; FIRB review thresholds reduced for sensitive-sector transactions in 2024.1
  • Power transition: AEMO Integrated System Plan committing A$122 billion across generation, storage, and transmission by 2050; AER revenue determinations on five-year cycles; ARENA renewables R&D grants.2
  • Biomedical: TGA software-as-medical-device framework; clinical-trial sponsor requirements harmonised with ICH GCP.
  • Food security: FSANZ Food Standards Code; export verification recognised internationally and aligned Trans-Tasman.

Where the regulatory architecture lives

Five Necessity-aligned regulated sectors, each with a mature statutory regime.

Critical materials: the A$4 billion Critical Minerals Strategy 2023-2030, the Critical Minerals Office at the Department of Industry, and FIRB review thresholds reduced for sensitive-sector transactions in 2024.1 Australia’s resource base in lithium, rare earths, and copper sits inside a tightening export-control architecture aligned with allied economies. Provenance, chain-of-custody, and verified ESG evidence are procurement requirements before a strategic mineral can be sold.

Power: the AEMO Integrated System Plan commits A$122 billion across generation, storage, and transmission investment by 2050; AER revenue determinations run on five-year cycles; ARENA funds renewables R&D.2 The transition pipeline is funded, regulated, and hard to reverse, even if individual projects slip. Storage, EVs, and distributed assets become grid participants, not passive loads, and the orchestration layer is under-built.

Biomedical: the TGA software-as-medical-device framework, the PBS reimbursement pathway, and clinical-trial sponsor requirements harmonised with ICH GCP. A TGA-regulated company can build a credible approval record that supports later entry into selected Asia-Pacific markets.

Food security: the FSANZ Food Standards Code governs control plans, traceability, residue testing, and recall readiness. Companies that ship into export markets sit inside a verification pathway recognised internationally and aligned Trans-Tasman.

Autonomous systems: national and state frameworks govern the entry of autonomous road, logistics, and maritime operations into public space. Safety and operating-domain proof clears the regulator before the deployment.

Market reference points

Two public-record outcomes anchor the Necessities in Australia. Eucalyptus, a digital-health company, has been valued at up to A$1.15 billion.3 Neara, an infrastructure and grid-modelling company serving the power Necessity, has been valued at roughly A$1.1 billion.3 Telix Pharmaceuticals, a radiopharmaceutical company in the biomedical Necessity, is publicly listed. The dominant exit lane runs to North American and European strategic acquirers.

Why now

The window is in flight between 2024 and 2030, setting hardest around 2027. The National Construction Code 2025 publishes May 2026 with phased state adoption through 2027. The Critical Minerals Strategy runs 2023-2030. The AEMO investment pipeline extends to 2050 but the regulatory determinations that gate it fall inside this window. A company entering now clears its barrier as the architecture sets.

Risks

The domestic addressable market is small. Companies that build only for Australian regulated buyers will not produce venture-scale outcomes. The thesis assumes early-stage entry with an explicit international revenue path.

The exit path is thinner than in the United States. ASX micro-cap listings exist but have priced down. Strategic exits to North American or European acquirers remain the dominant path. A company whose regulatory configuration is too Australia-specific may face thin acquirer interest.

Domestic talent supply in regulated-sector engineering and product roles constrains the candidate pool. The companies that match the profile are not numerous, though local regulatory familiarity can produce faster early licensing or procurement traction than a comparable company would face in a larger, more fragmented market.

Footnotes

  1. Australian Government, Critical Minerals Strategy 2023-2030; Department of Industry, Science and Resources, Critical Minerals Office. FIRB review thresholds revised for sensitive-sector transactions, 2024. ↩ ↩2

  2. Australian Energy Market Operator, Integrated System Plan; Australian Energy Regulator revenue determinations; Australian Renewable Energy Agency annual reports, 2024-25 vintage. ↩ ↩2

  3. Public valuation reporting for Eucalyptus, Neara, and the listing of Telix Pharmaceuticals. Cited as market reference points, not portfolio holdings; valuations per public record and subject to change. ↩ ↩2

Continue the record 02 The exits →